Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

Adocia SA (A89.F)

Compare
4.9550
+0.0650
+(1.33%)
At close: February 21 at 8:17:50 AM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,150
2,150
11,447
1,444
841
Cost of Revenue
765
765
1,839
1,264
1,457
Gross Profit
1,385
1,385
9,608
180
-616
Operating Expense
15,629
15,629
11,305
19,545
20,533
Operating Income
-14,244
-14,244
-1,697
-19,365
-21,149
Net Non Operating Interest Income Expense
-1,261
-1,261
-2,443
-2,259
-2,056
Pretax Income
-21,160
-21,160
-6,425
-22,754
-23,295
Tax Provision
2
2
476
--
29
Net Income Common Stockholders
-21,162
-21,162
-6,901
-22,754
-23,324
Diluted NI Available to Com Stockholders
-21,162
-21,162
-6,901
-22,754
-23,324
Basic EPS
-1.90
-1.90
-0.90
-3.20
-3.30
Diluted EPS
-1.90
-1.90
-0.90
-3.20
-3.30
Basic Average Shares
8,764.1550
14,087.3830
8,031.5270
7,057.6000
6,973.6390
Diluted Average Shares
8,764.1550
14,087.3830
8,031.5270
7,057.6000
6,973.6390
Total Operating Income as Reported
-14,244
-14,244
-1,698
-19,366
-21,148
Total Expenses
16,394
16,394
13,144
20,809
21,990
Net Income from Continuing & Discontinued Operation
-21,162
-21,162
-6,901
-22,754
-23,324
Normalized Income
-16,972.5000
-16,972.5000
-5,093.5000
-21,449
-23,478.0800
Interest Income
83
83
28
1
10
Interest Expense
1,308
1,308
2,292
2,249
2,066
Net Interest Income
-1,261
-1,261
-2,443
-2,259
-2,056
EBIT
-19,852
-19,852
-4,133
-20,505
-21,229
EBITDA
-19,353
-19,353
-3,576
-19,490
-20,030
Reconciled Cost of Revenue
765
765
1,839
1,264
1,457
Reconciled Depreciation
499
499
557
1,015
1,198
Net Income from Continuing Operation Net Minority Interest
-21,162
-21,162
-6,901
-22,754
-23,324
Total Unusual Items Excluding Goodwill
-5,586
-5,586
-2,410
-1,305
214
Total Unusual Items
-5,586
-5,586
-2,410
-1,305
214
Normalized EBITDA
-13,767
-13,767
-1,166
-18,185
-20,244
Tax Rate for Calcs
0.0003
0.0003
0.0003
--
0.0003
Tax Effect of Unusual Items
-1,396.5000
-1,396.5000
-602.5000
--
59.9200
12/31/2020 - 2/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0M4.SG Mersana Therapeutics Inc
0.4837
-3.88%
 
0M4.F Mersana Therapeutics, Inc.
0.4502
-2.58%
 
0M4.MU Mersana Therapeutics Inc
0.5106
-7.60%
 
SYRS Syros Pharmaceuticals, Inc.
0.1743
-0.85%
 
MRSN Mersana Therapeutics, Inc.
0.5332
+0.98%
 
MRNA Moderna, Inc.
35.53
+5.34%